genOway
Carol-Ann Eberle is a QSE and Project Manager at genOway since October 2016, specializing in client-oriented project management for genetically modified models, scientific support, and internal R&D project management. In addition, Carol-Ann has volunteered as a coach for the Athletic Club du Lyonnais since September 2023, training amateur runners for various trail races. Previous experience includes postdoctoral research at Sanofi, where research focused on Hepatitis B virus models, and visiting scientist roles at Inserm and University Hospital Heidelberg, concentrating on virology and biosafety protocols. Carol-Ann earned a PhD in Molecular Biology and Virology from the Medical University of Vienna and holds a BA in Natural Science from Trinity College Dublin.
This person is not in any teams
This person is not in any offices
genOway
1 followers
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate. Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.